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Abstract. The importance of phosphines in synthetic 
chemistry cannot be underestimated. Catalytic 
hydrophosphination offers an ideal method to prepare P–C 
bonds without the need for harsh reaction conditions or 
stoichiometric amounts of waste by-product. We herein 
report our studies into two biocompatible iron (III) 
complexes in hydrophosphination chemistry using 
diphenylphosphine under mild and benign reaction 
conditions (room temperature, solvent-free) and our 
extended exploration of hydrophosphination with 
phenylphosphine, which can be tuned to operate in the 
absence of catalyst under thermal conditions for single 
hydrophosphination or solvent-free with an iron (III) pre-
catalyst to generate the products of double 
hydrophosphination. 
Keywords: Homogeneous catalysis; Iron; Phosphines; 
Porphyrins; Schiff bases 
Introduction 
Hydrophosphination (HP),[1] the addition of a P–H 
bond across an unsaturated bond, is a powerful tool in 
synthetic chemistry: it has the potential to be 100% 
atom economic, has impressive functional group 
tolerance in comparison to many traditional routes of 
P–C bond formation[2] and gives access to vital 
primary, secondary or tertiary phosphines depending 
upon chemoselectivity and/or the phosphorus source. 
HP with an iron pre-catalyst is rare, with only a 
handful of examples reported in the literature.[3] The 
attraction of iron lies in its abundance and resulting 
cost effectiveness: it is a sustainable, non-toxic base 
metal with which to develop catalysis. Seminal work 
in the area of iron catalyzed HP of alkenes was 
presented by Gaumont and co-workers[3c] using only 
FeCl2 or FeCl3 to furnish the anti-Markovnikov 
product (cf. 2, Scheme 1) or highly desirable 
Markovnikov products. Following this work, we 
reported the use of a highly active iron (III) salen-μ-
oxo complex (1, Scheme 1) which catalyzes the HP 
of activated alkenes with a remarkably low catalyst 
loading of 0.5 mol%.[3d] We questioned whether this 
reactivity is limited to 1, or whether other N-ligands 
also facilitate HP when in a metal-μ-oxo coordination 
environment, specifically iron (III) porphyrin 
complex 3.[4] We also wished to explore the limits of 
the reactivity: catalysis with complex 1 appears to be 
restricted to activated alkenes, but we have not 
explored the potential of using an activated primary 
phosphine in catalysis i.e. phenylphosphine. There 
are limited examples of HP with primary phosphines 
in the literature. Examples include Waterman’s 
elegant and mild Zr-catalyzed route which can be 
tuned for single or double hydrofunctionalization 
products (cf. 4 and 5 respectively, Scheme 1), 
depending on reagent stoichiometries, and is effective 
for unactivated alkenes such as 1-hexene.[5] 
Waterman and Wright also report tin-mediated HP 
which operates for styrene, 2,3-butadiene, phenyl 
acetylene and diphenylacetylene[6] and finally 
publications from Sarazin, Carpentier and Trifonov[7] 
on rare earth catalyzed HP. These latter systems 
operate at 70 °C or below on styrene where a 1:1 ratio 
of styrene:H2PPh gives high levels of selectivity for 
the secondary phosphine product (cf. 4, Scheme 1).  
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Scheme 1. Hydrophosphination of activated alkenes under 
thermal or catalytic conditions. 
The desire to harness and understand the catalytic 
potential of iron, in particular the use of iron 
complexes which do not need activation is an area of 
interest. In the wider field of 
hydrofunctionalization,[8] iron has demonstrated its 
wide-reaching potential across a range of 
transformations, not least in catalytic 
hydrophosphination[3a, c] and 
hydrophosphonylation.[3b, 9] In our continued efforts 
to develop transformations of phosphines mediated 
by iron, we proceeded to investigate the use of air-
stable iron porphyrin-μ-oxo complex, 3, for the HP of 
activated alkenes with diphenylphosphine and 
compare to the activity observed with 1. We have 
also extended reactivity to phenylphosphine in the 
hydrophosphination of activated alkenes using 1 and 
3. 
Results and Discussion 
Reactions with HPPh2 
To initiate our study we compared the catalytic 
competency of complex 3 to 1 in the HP of styrene 
with diphenylphosphine across a range of different 
solvents (Table 1). Unsurprisingly, at high catalyst 
loading (5 mol%) both pre-catalysts are excellent at 
mediating this transformation. While it is difficult to 
argue against the biocompatible, non-toxic and easy 
to handle nature of both the iron porphyrin and salen 
systems, the reactions remain mild: excellent 
spectroscopic yield (Spec. Yield) is achieved in most 
solvents at room temperature. It is worth noting the 
competency when the reaction is performed in 
alcohols and neat (Entries 6 and 7).  We have already 
reported just how active 1 is at low catalyst loading 
and indeed, when the reaction is performed neat in 
the presence of 0.5 mol% 3, the yield of 2a remains at 
96%. 
 
Table 1. Optimization of HP reactivity in different 
solvents. 
 
Entry Solvent 
Pre-cat: 1 
2a Spec. Yield 
(%)a 
Pre-cat: 3 
2a Spec. Yield 
(%)a 
1 toluene 76 70 
2 dichloromethane 98 98 
3 tetrahydrofuran 84 88 
4 acetonitrile 89 84 
5 pentane - 65 
6 ethanol 92b 35 
7 none 98 96 
General reaction conditions: styrene (120 μL, 1.04 mmol, 
1.82 eq), HPPh2 (100 μL, 0.57 mmol), 1 or 3 (0.0029 
mmol, 0.5 mol%), 24 h, RT, inert atmosphere. a) Spec. 
Yield = spectroscopic yield, determined by 1H NMR 
spectroscopy using 1,2-DCE as a standard. b) Methanol 
used as solvent. 
We then proceeded to explore the substrate scope 
with pre-catalyst 3 under the optimized reaction 
conditions. The reaction is performed solvent-free at 
room temperature for 24 h (Table 2). Unsurprisingly, 
the porphyrin complex performs competently in 
comparison to the simple Fe (III) salen-μ-oxo 
complex under similar reaction conditions, albeit in 
MeCN. However, interesting improvements in 
reactivity are seen with 4-chlorostyrene (Table 2, 
Entry 4) and 2- and 4-vinyl pyridine (Entries 10 and 
11), where the reaction time and temperatures are 
reduced compared to those when 1 is employed. The 
improved reactivity, particularly with 2-vinylpyridine, 
could be attributed to the sterically congested reaction 
environment: the 4-coordinate porphyrin ligand 
surrounds the iron center and prevents competitive 
ligation and catalyst deactivation by the product, 2j. 
Aguirre et al. have already demonstrated that 2j is a 
good ligand for Suzuki cross-coupling,[10] so it is 
possible that competitive ligation could occur at the 
iron center. The activity of 1 and 3 in MeCN was 
compared: the turnover frequency for the formation 
of 2a over the initial 30 minutes is 80 h-1, slowing to 
55 h-1 after one hour using 1 compared to 33 h-1 for 
the first 30 minutes and only slowing marginally to 
30 h-1 after one hour for complex 3. It should be 
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noted that for simple styrenes reactions catalyzed by 
1 tend to be complete within 10 to 16 h, whereas 
reactions with 3 tend to need the full 24 h to go to 
completion. To probe reaction mechanism, the radical 
trap TEMPO (2,2,6,6-tetramethylpiperidine 1-oxyl) 
was added to the HP reactions using both 1 and 3; 
there is little variation in yield suggesting that 
catalysis is not radical mediated. 
Table 2. Substrate scope for thermal hydrophosphination 
using HPPh2. 
Entry Product  
Pre-cat: 1 
Spec. 
Yielda 
[Isolated 
yield], % 
Pre-cat: 3 
Spec. 
Yieldb 
[Isolated 
yield], % 
1 
 
2a 100[89] 96 [73] 
2 
 
2b 96 [79] [96] 
3 
 
2c 97 [89] 75 [71] 
4 
 
2d 100 [74]c 83 [72] 
5 
 
2e 82 [65] 85 [67] 
6 
 
2f 85 [83] 89 [35] 
7 
 
2g 85 [58]d [85]a 
8 
 
2h 100 [95] 73 [35] 
9 
 
2i 98 [98] [82] 
10 
 
2j 92 [86]e 96 [62] 
11 
 
2k 80 [75]e 75 [72] 
 
12 
 
 
2l 
 
80 [69] 
 
79 [71] 
 
13 
 
 
2m 
 
93 [76] 
 
99 [74] 
General reaction conditions: alkene (1.04 mmol, 1.82 eq), 
HPPh2 (100 μL, 0.57 mmol), 1 or 3 (0.0029 mmol, 0.5 
mol%), neat or MeCN (0.35 mL), 24 h, RT, Ar. a) Reaction 
performed in MeCN (350 μL). Spec. Yield = spectroscopic 
yield, determined using 1H NMR spectroscopy with 1,2-
DCE as a standard. b) Reaction performed neat, 
spectroscopic yield determined using 1H NMR 
spectroscopy with 1,2-DCE as a standard. c) 114 h. d) 60 °C. 
e) 72 h. 
To prove the synthetic utility of this transformation 
and the benefits of using an air-stable pre-catalyst, the 
reaction of HPPh2, styrene and 3 was performed in a 
round-bottom flask fitted with a septum under a 
steady stream of N2. The reaction was scaled to use 
2.3 mmol (0.4 mL) HPPh2, 4.2 mmol (0.48 mL) 
styrene and 0.5 mol% (13.6 mg) 3. Product 2a was 
obtained in 85% spectroscopic yield, 63% (0.66 g) 
isolated yield.  
 
Reactions with H2PPh 
Overall, the ease and scale in which 1 and 3 can be 
synthesized led us to investigate their ability to 
catalyze the reaction of phenylphosphine and styrene. 
We commenced this investigation by reacting 
phenylphosphine with styrene in the presence of iron 
pre-catalyst at room temperature, using a range of 
reaction conditions. We were somewhat surprised to 
find that very little reaction takes place in the 
presence of 1. With 5 mol% 3 at RT, 37% of the 
single addition product (4a, SHP, where only one 
equivalent of styrene reacts with phenylphosphine 
generating the secondary phosphine) is obtained after 
24 h in the absence of solvent. Extending the reaction 
time to 72 h increases the yield to 62%. Although a 
good yield, and a rare example of SHP at room 
temperature,[5-7] the prolonged reaction time is 
somewhat limited: we decided to probe the potential 
for catalyst-free thermal reactivity. Undertaking the 
hydrophosphination procedure in the absence of 
catalyst, under thermal conditions, gives good 
conversion to the SHP product (Scheme 2a). After a 
short optimization process we found that a good yield 
of 4a could be obtained with thermal treatment at 
80 °C (61% 4a after 18 h at 80 °C in MeCN). 
Addition of a further two equivalents of styrene to 
this reaction mixture and thermal treatment gives no 
further conversion, with only trace amounts of 5a 
observed. Solvent is necessary for the reaction to 
proceed cleanly; when performed neat impurities can 
be seen in the 31P{1H} NMR. It is interesting to note 
that in our hands when a 1:1 ratio of 
phenylphosphine:styrene is reacted in C6D6 at 60 °C 
in a J-Young NMR tube 35% of 4a is obtained after 
16 h.[11] When the reaction is repeated in a Schlenk 
tube with stirring 60% 4a is obtained. This would 
suggest that at temperatures of 60 °C or greater, no 
catalyst is necessary and thermal conditions can be 
used, analogous to work from Alonso and co-workers 
with HPPh2.[12]   
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Scheme 2. Reactivity of styrene and phenylphosphine 
under a) thermal and b) catalytic conditions. 
Surprisingly, the thermal reaction of phenylphosphine 
with activated alkenes has never been reported. We 
decided to investigate whether this reactivity is 
substrate specific, but are pleased to report that a 
range of activated substrates undergo SHP with 
minimal conversion to the tertiary phosphine product 
under these reaction conditions (Table 3). Styrenes 
with functionality in the para-position undergo 
thermal SHP with only minor amounts of double 
addition (DHP, where two equivalents of styrene 
functionalize phenylphosphine furnishing a tertiary 
phosphine) being observed: electron-withdrawing and 
donating groups are tolerated, as well as styrenes with 
useful functionality, for example halogen-substituted 
styrenes (Entries 4, 5 and 8). Vinyl pyridines undergo 
hydrophosphination with phenylphosphine, but 
unfortunately the reaction appears to be less selective 
for the secondary phosphine product, with double 
hydrophosphination taking place readily: 2-vinyl 
pyridine undergoes HP with a 3:2 ratio of 4h:5h 
obtained (Entry 9), 4-vinyl pyridine gives poor yield 
of 4i, with multiple products observed by 31P{1H} 
NMR (Entry 10). Acrylates are tolerated under these 
reaction conditions (Entries 11 and 12).  
Table 3. Substrate scope for thermal hydrophosphination 
using H2PPh. 
Entry Styrene Product  
Spec. 
Yielda 
[Isolated 
yield], % 
1 
  
4a 61 [53] 
2 
  
4b 44 [40] 
3 
  
4c 82 [70] 
4 
  
4d 76 [66] 
5 
  
4e 93 [78] 
6 
  
4f 60 [55] 
7 
  
4g 79 [76] 
8 
 
 
4h 76  [61] 
(34)b  
 
9 
  
4i 60 (40)b 
  
10 
  
4j 35 [31] 
 
11 
  
 
4k 
 
81 [64] 
 
12 
  
 
4l 
 
74 [72] 
General reaction conditions: styrene (0.285 mmol, 1 eq), 
phenylphosphine (63 μL, 0.57 mmol, 2 eq), MeCN (200 
μL), 16 h, 80 °C, Ar. a) Spec. Yield = spectroscopic yield, 
determined by 1H NMR spectroscopy using THF as a 
standard. b) Product of double hydrophosphination 
observed, spectroscopic yield shown in brackets.  
Purification of the SHP products, even in the 
presence of DHP side-products, is trivial: the reaction 
mixture is subjected to vacuum to remove any 
unreacted H2PPh and volatile styrenes, then use of 
short path distillation apparatus or cold finger at 
reduced pressure with gentle heating to 60 °C allows 
distillation of products 4a to 4k away from any traces 
of DHP product or unreacted, non-volatile, styrenes. 
Unfortunately no reaction is observed with 
unactivated substrates; substrates primed for 
nucleophilic attack must be used, for example, allyl 
benzene and 1-hexene give only trace amounts of 
product. Similarly, the transformation with 
cyclohexylphosphine fails to deliver an appreciable 
amount of product. 
We then proceeded to investigate whether we could 
integrate thermal and catalytic HP. We anticipate that 
the electronic nature of phosphine products 4a to 4k 
is similar to that of diphenylphosphine and should 
thus be able to undergo iron catalyzed HP in the 
presence 1 or 3. By changing the reaction 
stoichiometries, the product of double 
hydrophosphination is observed (Scheme 2b). Using 
1, no reaction is obtained using DHP conditions at 
room temperature and heating to 40 °C is needed 
(Table 4). We envisage that this reaction proceeds via 
thermal SHP and on formation of small amounts of 
SHP product it is immediately transferred to an iron 
catalyzed HP cycle where it can undergo DHP, thus 
helping to drive forward the thermal process. 
Alternatively, it is possible to undertake thermal SHP 
at 80 °C to afford secondary phosphines of the form 4, 
followed by addition of catalyst and further reaction 
at RT to generate products of the form 5. Using the 
one pot procedure, 1.25 mol% 1 and heating to 40 °C, 
we observe clean formation of the DHP product, with 
only small quantities of unreacted SHP product 
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(<15%) and unreacted starting materials. In some Fe-
catalyzed HP reactions small quantities of side 
product are observed in the 31P NMR.[13] These are 
believed to be products of Michael addition,[14] where 
styrene starting material undergoes further attack by 
the HP product. This may hint at a potential reaction 
mechanism which proceeds via a zwitterionic 
intermediate. The reaction proceeds best neat, 
presumably the increased concentration results in 
more favorable DHP. However, in an effort to use 
milder reaction conditions, when the catalyst loading 
is increased the reaction does not proceed cleanly and 
mixtures of products start to form. On the other hand 
3 is an excellent pre-catalyst for DHP at RT and, 
unlike 1, side-products are not obtained at the higher 
catalyst loading of 5 mol%. 
 
Table 4. Substrate scope for catalytic double 
hydrophosphination. 
 
Entry Product  
Pre-cat: 1 
Spec. 
Yield,a % 
 
Pre-cat: 3 
Spec. 
Yielda 
[Isolated 
yield], % 
1 
 
5a 66 81 [79] 
2 
 
5b 30 63 [62] 
3 
 
5c 78 74 [70] 
4 
 
5d 60 96 [89] 
5 
 
5e 58 [71] 
6 
 
5f 36 92 [88] 
General reaction conditions: styrene (2.28 mmol, 4 eq), 
phenylphosphine (63 μL, 0.57 mmol, 1 eq), 1 (1.25 mol%) 
or 3 (5 mol%), neat, 24 h, 40 °C or RT, Ar. a) Spec. Yield = 
spectroscopic yield, determined by 1H NMR spectroscopy 
using 1,2-DCE as a standard.  
The phosphine products are oils at room temperature, 
however, the structure of phosphine 5a was 
confirmed by ligation to iron, which is achieved in 
good yield (65% Fe-5a) by stirring two equivalents 
of the ligand with FeCl2·THF1.5 at room temperature 
in dry THF (Figure 1). Precipitation of the iron 
complex is observed within minutes and can be 
isolated by removal of solvent by filtration followed 
by washing with cold pentane. The iron complex is 
obtained as a distorted tetrahedral complex with bond 
lengths of 2.433(1) and 2.415(1) Å, for Fe–P1 and 
Fe–P2 respectively and 2.232(1) and 2.238(1) for Fe–
Cl1 and Fe–Cl2 respectively. 
Figure 1. X-ray crystal structure of complex Fe-5a 
(hydrogen atoms omitted for clarity and ellipsoids 
represented at 30% probability). Selected bond lengths (Å) 
Fe1–Cl1 2.232(1); Fe1–Cl2 2.238(1); Fe1–P1 2.433(1); 
Fe1–P2 2.415(1); P1–C1 1.827(4); P1–C9 1.830(4); P1–
C17 1.815(4); P2–C23 1.822(4); P2–C31 1.835(4); P2–
C39 1.818(4); C1–C2 1.533(6); C9–C10 1.540(5); C23–
C24 1.536(5); C31–C32 1.528(5). Selected bond angles 
(°): Cl2–Fe1–Cl1 127.30(4); Cl2–Fe1–P1 102.55(4); Cl1–
Fe1–P2 100.41(4); Cl2–Fe1–P2 111.64(4); Cl1–Fe1–P1 
111.04(4); P2–Fe1–P1 101.25(4). 
 
With easy access to chiral salen complexes we then 
questioned whether we could afford optically active 
tertiary phosphines using our methodology. By first 
applying thermal conditions to generate the SHP 
product, 4a, we should then be able to use a chiral 
iron pre-catalyst to install a second alkyl substituent 
stereoselectively. P-stereogenic phosphines have 
found extensive use in metal mediated asymmetric 
catalysis,[1a, 15] notably in early leading research from 
Knowles into asymmetric hydrogenations.[16] 
Although excellent examples of transition metal 
catalyzed enantioselective HP exist,[15a-d, 17] this 
would be an unusual example of iron mediating an 
enantioselective HP reaction, with the other leading 
literature examples being stoichiometric studies[18] or 
of intermolecular hydrophosphonylation.[3b]  
We initiated our investigations by preparing the 
Jacobsen’s ligand motif and ligating to Fe to form the 
corresponding μ-oxo complex, 6.[19] When 4a is 
reacted in the presence of two equivalents 4-
chlorostyrene, 0.5 mol% 6 at 60 °C for 60 h 90% 7 is 
obtained (Scheme 3). Unfortunately no 
enantioinduction is obtained with pre-catalyst 6 
which was determined by oxidation of the isolated 
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phosphine, 7, with two equivalents of H2O2 and 
extraction of the phosphine oxide into CH2Cl2 to give 
a stable product that can be studied using chiral 
separation techniques. It is worth noting that for 
product 7 Kagan’s amide[20] and a selection of 
lanthanide shift reagents (Eu(FOD)3 and Eu(hfc)3) do 
not give peak separation by both 1H and 31P{1H} 
NMR. Instead, circular dichroism was used to 
demonstrate that enantioinduction has not taken place. 
This could be due to rapid P-inversion at the Fe-
center,[21] particularly at the raised reaction 
temperature, and/or due to lack of stereocontrol 
induced by the metal complex. It is nonetheless a 
useful method to make unsymmetrically substituted 
tertiary phosphines. 
Scheme 3. Product of unsymmetrical HP. 
Conclusion 
In summary, we have demonstrated that an iron (III) 
porphyrin complex can catalyze the 
hydrophosphination of activated alkenes with 
diphenylphosphine. The transformation operates 
under environmentally benign conditions (solvent-
free, room temperature) with a low loading of a 
simple air-stable base-metal catalyst. In general, this 
porphyrin catalyst appears to be as active over as 
wide a range of alkene substrates as our original iron 
(III) salen complex.  We have also presented two new 
methods to functionalize activated alkenes with 
phenylphosphine; a thermal route which selectively 
forms the secondary phosphine products and an iron 
(III) salen catalyzed route which can furnish 
symmetrical tertiary phosphines in one pot or a two-
step method which can be used to synthesize 
unsymmetrically substituted tertiary phosphines. It is 
clear that iron pre-catalyst 6 is not able to induce 
enantioselective hydrophosphination and therefore 
further development is needed in this area in order to 
achieve this goal. 
Experimental Section 
General method for hydrophosphination using HPPh2 
and pre-catalyst 3 
Carried out under an argon atmosphere in an M-Braun 
glove box. 3 (0.5 mol%) was weighed out into a Schlenk 
tube. Styrene (1.04 mmol, 1.86 eq) was added followed by 
diphenylphosphine (100 µL, 0.57 mmol, 1 eq). After 
stirring at room temperature for 24 h, the Schlenk tube was 
placed under vacuum and the excess starting styrene and 
solvent removed. For spectroscopic yields reaction 
solutions were exposed to air and filtered through a silica 
gel plug using CH2Cl2. Solvent was removed by blowing 
nitrogen over the oil before addition of 1,2-dichloroethane 
as an integration standard. CDCl3 was used as the NMR 
solvent. All products obtained have been previously 
reported and characterised,[3d] NMR spectra for isolated 
products is provided.[13]  
General method for thermal single hydrophosphination 
The reaction was prepared under an argon atmosphere in 
an M-Braun glove box. Styrene (0.285 mmol, 1 eq) was 
placed in a Schlenk tube, acetonitrile (200 µL) and 
phenylphosphine (63 µL, 0.57 mmol, 2 eq) were added. 
After stirring at 80 °C for 16 h, the Schlenk tube was 
placed under vacuum and the excess starting styrene and 
solvent removed leaving a colorless oil. A spectroscopic 
yield was obtained under an atmosphere of argon prior to 
the sample being purified by short-path distillation under 
reduced pressure (2 × 10-2 mbar, 60 °C).  
General method for catalytic double 
hydrophosphination 
The reaction was prepared under an argon atmosphere in 
an M-Braun glove box. 1 (4.7 mg, 1.25 mol%) was 
weighed out into a Schlenk tube. Styrene (2.28 mmol, 4 
eq) was added to this followed by and phenylphosphine 
(63 µL, 0.57 mmol, 1 eq). After stirring at 40 °C for 24 h, 
the Schlenk tube was placed under vacuum and the excess 
starting styrene removed. A spectroscopic yield was 
obtained prior to purification by column chromatography 
(1% EtOAc/petroleum ether). 
General method for catalytic unsymmetrical double 
hydrophosphination 
The reaction was prepared under an argon atmosphere in 
an M-Braun glove box. 6 (0.5 mol%) was weighed out into 
a Schlenk tube. CH3CN (200 µL) was added to this 
followed by 4a (0.5 mmol, 1 eq) and a substituted styrene 
(1 mmol, 2 eq) was added. After stirring at 60 °C for 60 h, 
the Schlenk tube was placed under vacuum and the excess 
starting styrene and solvent removed. A spectroscopic 
yield was obtained prior to purification by column 
chromatography (1% EtOAc/petroleum ether). 
Characterization Data 
Table 3, Entry 1, 4a 
Colourless oil (32 mg, 53%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.34 (s, 2H), 7.13 - 7.07 (m, 6H), 6.94 - 6.93 (m, 
2H), 4.09 (dm, 1H, J = 210 Hz), 2.61 - 2.56 (m, 2H), 1.93 - 
1.84 (m, 2H); 13C{1H} NMR (125 MHz, 298 K, CDCl3) δ 
142.1, 139.7, 135.7 (d, J = 4.8 Hz), 133.6 (d, J = 1.9 Hz), 
128.3 (d, J = 4.8 Hz), 128.1, 127.9, 125.9, 34.5 (d, J = 2.9 
Hz), 25.2 (d, J = 3.8 Hz); 31P{1H} NMR (202 MHz, 298 K, 
CDCl3) δ −52.3; IR (solid) ν 2912, 2283, 1602, 1495, 1434, 
740, 720, 692 cm-1; HRMS (EI) 213.0828 (calcd.), 
213.0834 (obs.). 
Table 3, Entry 2, 4b  
Colourless oil (26 mg, 40%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.36 - 7.33 (m, 2H), 7.07 - 7.04 (m, 3H), 6.95 (d, 
2H, J = 7.9 Hz), 6.88 (d, 2H, J = 7.9 Hz), 4.10 (dm, 1H, J 
= 206.3 Hz), 2.67 - 2.53 (m, 2H), 2.12 (s, 3H), 1.90 - 1.80 
(m, 2H); 13C{1H} NMR (125 MHz, 298 K, CDCl3) δ 139.1 
(d, J = 7.3 Hz), 135.8 (d, J = 12.3 Hz), 133.5 (d, J = 15.5 
Hz), 129.1, 129.0, 128.3 (d, J = 5.6 Hz), 128.1, 128.0, 34.0 
(d, J = 8.1 Hz), 25.3 (d, J = 13.5 Hz), 20.7; 31P{1H} NMR 
(202 MHz, 298 K, CDCl3) δ −53.0; IR (solid) ν 2920, 2283, 
1591, 1515, 1436, 807, 740 cm-1; HRMS (EI) 227.0984 
(calcd.), 227.0987 (obs.). 
Table 3, Entry 3, 4c  
Colourless oil (40 mg, 70%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.40 - 7.32 (m, 2H), 7.09 - 7.00 (m, 3H), 6.88 (d, 
2H, J = 10 Hz), 6.76 (d, 2H, J = 10 Hz),  4.12 (dm, 1 H, J = 
 7 
206.3 Hz), 3.33 (s, 3H), 2.65 - 2.56 (m, 2H), 1.98 - 1.86 (m, 
2H); 31P{1H} NMR (202 MHz, 298 K, CDCl3) δ −52.8; IR 
(solid) ν cm-1 2930, 2283, 1610, 1511, 1434, 820, 741, 
695; HRMS (EI) 243.0933 (calcd.), 243.0936 (obs.). 
Table 3, Entry 4, 4d   
Colourless oil (47 mg, 66%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.34 - 7.32 (m, 2H), 7.10 - 7.08 (m, 3H), 7.06 (d, 
2H, J = 8.3 Hz), 6.58 (d, 2H, J = 8.3 Hz), 4.05 (ddd, 1 H, J 
= 206.4, 7.8, 5.9 Hz), 2.46 - 2.35 (m, 2H), 1.80 - 1.66 (m, 
2H); 13C{1H} NMR (125 MHz, 298 K, C6D6) δ 139.8 (d, J 
= 7.6 Hz), 134.7 (d, J = 12.4 Hz), 132.9 (d, J = 16.2 Hz) 
131.1, 128.9, 127.7, 127.5, 127.3, 33.0 (d, J = 8.6 Hz), 
24.2 (d, J = 14.3 Hz); 31P{1H} NMR (202 MHz, 298 K, 
CDCl3) δ −53.0; IR (solid) ν 2923, 2285, 1490, 1434, 734, 
695 cm-1; HRMS (EI) 265.0544 (calcd.), 265.0548 (obs.). 
Table 3, Entry 5, 4e  
Colourless oil (65 mg, 78%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.34 - 7.30 (m, 2H), 7.20 (d, 2H, J = 8.3 Hz), 7.08 
- 7.07 (m, 3H), 6.51 (d, 2H, J = 8.3 Hz), 4.03 (ddd, 1H, J = 
206.4, 7.3, 5.9 Hz), 2.41 - 2.32 (m, 2H), 1.81 - 1.64 (m, 
2H); 13C{1H} NMR (125 MHz, 298 K, C6D6) δ 133.5 (d, J 
= 15.6 Hz), 131.3, 129.8, 128.3 (d, J = 5.7 Hz), 128.2, 
128.1, 128.0, 127.9, 33.6 (d, J = 8.3 Hz), 24.8 (d, J = 13.7 
Hz); 31P{1H} NMR (202 MHz, 298 K, CDCl3) δ −52.7; IR 
(solid) ν 2924, 2283, 1586, 1487, 1434, 801, 741, 695 cm-
1; HRMS (EI) 291.1297 (calcd.), 291.1304 (obs.). 
Table 3, Entry 6, 4f 
Colourless oil (44 mg, 55%). 1H NMR (400 MHz, 298 K, 
C6D6) δ 7.43 - 7.39 (m, 1H), 7.31 - 7.25 (m, 4H), 7.08 - 
7.05 (m, 2H), 6.74 - 6.72 (m, 1H), 6.65 - 6.63 (m, 1H), 
4.00 (d, 1H, J = 205.8 Hz), 2.43 - 2.37 (m, 2H), 1.74 - 1.62 
(m, 2H); ); 13C{1H} NMR (100 MHz, 298 K, C6D6) δ 
135.8, 134.3 (d, J = 15.6 Hz), 133.3 (d, J = 19.5 Hz), 130.0, 
129.2, 129.1, 128.9, 125.9, 34.8 (d,  J = 8.1 Hz), 25.3 (d, J 
= 14.5 Hz); 31P{1H} NMR (162 MHz, 298 K, C6D6) δ 
−52.6; IR (solid) ν 3073, 2310, 1550, 1479, 1366, 759, 655 
cm-1. 
Table 3, Entry 7, 4g 
Colourless oil (61 mg, 76%). 1H NMR (400 MHz, 298 K, 
C6D6) δ 7.55 - 7.51 (m, 1H), 7.50 - 7.47 (m, 2H), 7.43 - 
7.34 (m, 4H), 7.23 - 7.19 (m, 2H), 7.09 - 7.03 (m, 3H), 
6.97 - 6.95 (m, 2H), 4.11 (ddd, 1H, J = 207.4, 7.6, 6.4 Hz), 
2.72 - 2.57 (m, 2H), 1.97 - 1.85 (m, 2H); 13C{1H} NMR 
(100 MHz, 298 K, C6D6) δ 141.8 (d, J = 11.3 Hz), 141.2, 
139.1 (d, J = 2.2 Hz), 133.6 (d, J = 15.5 Hz), 128.7, 128.6, 
127.2, 127.1, 127.0, 127.0, 126.9, 34.1 (d, J = 8.2 Hz), 
25.1 (d, J = 13.7 Hz); 1P{1H} NMR (162 MHz, 298 K, 
C6D6) δ −52.7; IR (solid) ν 3065, 2284, 1602, 1432, 820, 
747, 695 cm-1; HRMS (EI) 291.1304 (calcd.), 291.1297 
(obs.).  
Table 3, Entry 8, 4h 
Colourless oil (52 mg, 61%). 1H NMR (400 MHz, 298 K, 
C6D6) δ 7.28 - 7.26 (m, 2H), 7.15 (m, 2H, partially 
obscured by solvent), 7.08 - 7.04 (m, 3H), 6.69 - 6.65 (m, 
1H), 6.60 - 6.59 (m, 1H), 3.98 (dm, 1H, J = 206.5 Hz), 
2.38 - 2.29 (m, 2H), 1.74 - 1.57 (m, 2H); 13C{1H} NMR 
(101 MHz, 298 K, C6D6, C-P not observed) δ 133.5 (d, J = 
15.3 Hz), 131.2, 129.8, 129.7, 129.0, 128.4 (d, J = 5.6 Hz), 
128.0, 126.6, 122.5, 33.9 (d, J = 8.6 Hz), 24.6 (d, J = 14.0 
Hz); 31P{1H} NMR (162 MHz, 298 K, CDCl3) δ −52.6; IR 
(solid) ν 2923, 2283, 1593, 1567, 1475, 1434, 882, 781, 
741, 694 cm-1; HRMS (EI) 293.0089 (calcd.), 293.0095 
(obs.).  
Table 3, Entry 9, 4i   
Colourless oil. 1H NMR (500 MHz, 298 K, C6D6) δ 8.54 - 
8.53 (m, 1H), 7.59 - 7.57 (m, 1H), 7.54 - 7.51 (m, 2H), 
7.34 - 7.32 (m, 3H), 7.12 - 7.10 (m, 2H), 4.18 (ddd, 1H, J 
= 211.0, 7.9, 6.3 Hz), 2.98 - 2.91 (m, 2H), 2.31 - 2.22 (m, 
2H); 13C{1H} NMR (125 MHz, 298 K, CDCl3) δ 161.4 (d, 
J = 7.8 Hz), 149.3, 136.3, 133.6 (d, J = 15.4 Hz), 128.5, 
128.4, 128.2, 122.7, 121.2, 36.8 (d, J = 7.5 Hz), 23.2 (d, J 
= 12.5 Hz); 31P{1H} NMR (202 MHz, 298 K, CDCl3) δ 
−51.7; IR (solid) ν 2913, 2279, 1590, 1474, 1433, 811, 741 
cm-1; HRMS (EI) 216.0937 (calcd.), 216.0939 (obs.). 
Table 3, Entry 10, 4j  
Colourless oil (19 mg, 31%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 8.51 - 8.50 (m, 2H), 7.32 - 7.29 (m, 2H), 7.09 - 
7.07 (m, 3H), 6.51 - 6.50 (m, 2H), 4.00 (ddd, 1H, J = 206.9, 
7.8, 5.9 Hz), 2.36 - 2.25 (m, 2H), 1.73 - 1.62 (m, 2H); 
13C{1H} NMR (125 MHz, 298 K, CDCl3) δ 150.0, 133.5 (d, 
J = 15.6 Hz), 128.4 (d, J = 5.7 Hz), 128.2, 128.1 (d, J = 8.6 
Hz), 127.9, 123.2, 33.4(d, J = 7.6 Hz), 23.7 (d, J = 14.3 
Hz); 31P{1H} NMR (202 MHz, 298 K, CDCl3) δ −52.5; 
HRMS (EI) 232.0886 (calcd.), 232.0889 (obs.). 
Table 3, Entry 11, 4k 
Colourless oil (36 mg, 64%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.34 - 7.29 (m, 2H), 7.03 (m, 3H), 4.02 (d, 1H, J = 
207.4 Hz), 3.28 (s, 3H), 2.18 - 2.17 (m, 2H), 1.88 - 1.86 (m, 
2H); 31P{1H} NMR (202 MHz, 298 K, CDCl3) δ −51.2; IR 
(solid) ν 2923, 2280, 1593, 1568, 1475, 1434 cm-1; HRMS 
(EI) 181.0413 (calcd.), 181.0414 (obs.). 
Table 3, Entry 12, 4l 
Colourless oil (49 mg, 72%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.32 - 7.29 (m, 2H), 7.03 - 7.02 (m, 3H), 4.06 (ddd, 
1H, J = 207.9, 8.3, 5.9 Hz), 3.95 - 3.92 (m, 2H), 2.28 - 2.19 
(m, 2H), 2.00 - 1.89 (m, 2H), 1.38 - 1.32 (m, 2H), 1.18 - 
1.12 (m, 2H), 0.76 - 0.73 (m, 3H); 13C{1H} NMR (125 
MHz, 298 K, CDCl3, carbonyl carbon not observed) δ 
134.4, 129.1 (d, J = 5.7 Hz), 128.8 (d, J = 18.1 Hz), 128.7, 
64.6, 33.5 (d, J = 8.6), 31.3, 19.7, 19.3, 19.2, 14.1; 31P{1H} 
NMR (202 MHz, 298 K, CDCl3) δ −51.2; IR (solid) ν 2958, 
2873, 2285, 1730, 1600, 1464, 1435, 1388, 803, 737 cm-1; 
HRMS (EI) 291.1303 (calcd.), 291.1297 (obs.).  
Table 4, Entry 1, 5a 
Colourless oil (144 mg, 79%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.50 - 7.48 (m, 2H), 7.20 - 7.18 (m, 6H), 7.14 - 
7.04 (m, 3H), 7.00 - 6.99 (m, 4H), 2.67 - 2.54 (m, 4H), 
1.93 - 1.81 (m, 4H); 13C{1H} NMR (125 MHz, 298 K, 
CDCl3) δ 142.8 (d, J = 11.6 Hz), 138.0 (d, J = 14.9 Hz), 
132.6 (d, J = 18.9 Hz), 129.1, 128.6, 128.5, 128.2, 126.0, 
32.3 (d, J = 15.3 Hz), 30.3 (d, J = 12.9 Hz); 31P{1H} NMR 
(121.5 MHz, 298 K, CDCl3) δ −23.4; HRMS (EI) 
319.1610 (calcd.), 319.1614 (obs.). Unknown side-
products observed in reaction catalyzed by 1. 
Table 4, Entry 2, 5b 
Colourless oil (134 mg, 62%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.66 - 7.63 (m, 2H), 7.47 - 7.42 (m, 3H), 7.13 (d, 
4H, J = 8.6 Hz), 6.88 (d, 4H, J = 8.6 Hz), 3.82 (s, 6H), 
2.75 - 2.64 (m, 4H), 2.13 - 2.01 (m, 4H); 13C{1H} NMR 
(125 MHz, 298 K, CDCl3) δ 157.9, 134.9 (d, J = 11.7 Hz), 
132.6 (d, J = 18.8 Hz), 129.3 (d, J = 6.3 Hz), 129.1, 129.0, 
128.5 (d, J = 7.0), 113.9, 55.3, 31.4 (d, J = 15.3 Hz), 30.6 
(d, J = 12.9 Hz); 31P{1H} NMR (202 MHz, 298 K, CDCl3) 
δ −24.4; IR (solid) ν 2931, 1610, 1583, 1509, 1463, 1434, 
817, 742, 696 cm-1; HRMS (EI) 379.1821 (calcd.), 
379.1826(obs.). 
Table 4, Entry 3, 5c 
Colourless oil (138 mg, 63%). 1H NMR (300 MHz, 298 K, 
C6D6) δ 7.53 - 7.52 (m, 2H), 7.27 - 7.25 (m, 3H), 7.17 (d, 
4H, J = 8.3 Hz), 6.74 (d, 4H, J = 8.3 Hz), 2.54 - 2.46 (m, 
4H), 1.84 - 1.74 (m, 4H); 13C{1H} NMR (125 MHz, 298 K, 
CDCl3) δ 142.8 (d, J = 11.6 Hz), 132.5 (d, J = 18.9 Hz), 
129.0, 128.6, 128.5, 128.4, 128.1, 126.0, 32.2 (d, J = 15.3 
Hz), 30.3 (d, J = 12.9 Hz); 31P{1H} NMR (202 MHz, 298 
K, CDCl3) δ −24.6. Unknown side-products observed in 
reaction catalyzed by 1. 
Table 4, Entry 4, 5d 
Colourless oil (217 mg, 80%). 1H NMR (500 MHz, 298 K, 
C6D6) δ 7.49 - 7.47 (m, 2H), 7.34 - 7.30 (m, 7H), 6.95 - 
6.93 (m, 4H), 2.60 - 2.48 (m, 4H), 1.99 - 1.86 (m, 4H); 
13C{1H} NMR (125 MHz, 298 K, CDCl3) δ 141.4 (d, J = 
11.3 Hz), 137.3 (d, J = 14.5 Hz), 132.5 (d, J = 19.2 Hz), 
131.4, 129.8, 129.2, 128.5 (d, J = 7.2 Hz), 119.7, 31.6 (d, J 
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= 15.7 Hz), 30.2 (d, J = 13.2 Hz); 31P{1H} NMR (202 
MHz, 298 K, C6D6) δ −24.2. 
Table 4, Entry 5, 5e 
Colourless oil (224 mg, 82%). 1H NMR (400 MHz, 298 K, 
C6D6) δ 7.36 (mbr, 2H), 7.16 - 7.15 (m, 3H, partially 
obscured by solvent), 7.13 - 7.12 (m, 4H, partially 
obscured by solvent), 6.73 - 6.64 (m, 4H), 2.39 - 2.32 (m, 
4H), 1.67 - 1.55 (m, 4H); 13C{1H} NMR (101 MHz, 298 K, 
CDCl3) δ 144.9 (d, J = 11.5 Hz), 132.7, 132.5, 131.2, 130.0, 
129.3, 129.2, 128.7 (d, J = 7.3 Hz), 126.9, 122.5, 32.0 (d, J 
= 16.0 Hz), 30.1 (d, J = 13.3 Hz); 31P{1H} NMR (162 
MHz, 298 K, CDCl3) δ −23.5. Unknown side-products 
observed in reaction catalyzed by 1. 
Table 4, Entry 6, 5f 
Colourless oil (161 mg, 88%). 1H NMR (400 MHz, 298 K, 
CDCl3) δ 8.56 - 8.55 (m, 2H), 7.66 - 7.58 (m, 4H), 7.42 - 
7.40 (m, 3H), 7.15 - 7.12 (m, 4H), 2.96 - 2.89 (m, 4H), 
2.27 - 2.23 (m, 4H); 13C{1H} NMR (125 MHz, 298 K, 
CDCl3) δ 161.9, 149.2, 136.5, 132.6 (d, J = 19.1 Hz), 129.0, 
128.5, 128.4, 122.6, 121.1, 34.5 (d, J = 16.2 Hz), 28.0 (d, J 
= 12.4 Hz); 31P{1H} NMR (162 MHz, 298 K, CDCl3) δ 
−22.9; HRMS (EI) 336.1392 (calcd.), 336.1395 (obs.). 
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